Understanding the various processes involved in viral infection and replication is necessary for developing strategies to treat viral infections. Treating viral infections is particularly challenging because many viruses use the genetic and metabolic machinery of the host cell to reproduce themselves. Another challenge is the difficulty of developing antiviral drugs that are selectively toxic for the virus and do not damage the host cells. The key to developing antiviral drugs is to identify processes or enzymes that the virus uses but that are not used by or necessary for the normal functioning of a host cell. Part D - How Can Antiviral Medications Selectively Interfere with Viral Infection Cycles? Select strategies that are likely to interfere with viral infection and replication but will NOT damage the normal functioning of host cells. Select all that apply. View Available Hint(s)for Part D inhibiting host cell RNA polymerase blocking host cell receptors that serve as sites for viruses to attach inhibiting viral assembly and maturation processes inhibiting translation of mRNA by ribosomes inhibiting viral-encoded DNA polymerase blocking attachment sites on the virus surface inhibiting host cell DNA polymerase inhibiting cytoskeletal function of host cells to prevent receptor-mediated endocytosis inhibiting the release of viruses from the host cell